JP2014518071A - カロリー制限およびカロリー制限模倣物の同定用マーカー - Google Patents

カロリー制限およびカロリー制限模倣物の同定用マーカー Download PDF

Info

Publication number
JP2014518071A
JP2014518071A JP2014516069A JP2014516069A JP2014518071A JP 2014518071 A JP2014518071 A JP 2014518071A JP 2014516069 A JP2014516069 A JP 2014516069A JP 2014516069 A JP2014516069 A JP 2014516069A JP 2014518071 A JP2014518071 A JP 2014518071A
Authority
JP
Japan
Prior art keywords
tissue
polynucleotide
probe
subject
genes listed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014516069A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014518071A5 (https=
Inventor
アンジェラ マスタロウディス,
スティーブ ウッド,
トーマス アルバート プロラ,
ジェイミー ルイス バーガー,
リチャード ワインドラック,
ジョセフ チャン,
Original Assignee
エヌエスイー プロダクツ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エヌエスイー プロダクツ インコーポレイテッド filed Critical エヌエスイー プロダクツ インコーポレイテッド
Publication of JP2014518071A publication Critical patent/JP2014518071A/ja
Publication of JP2014518071A5 publication Critical patent/JP2014518071A5/ja
Priority to JP2016165596A priority Critical patent/JP6904676B2/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
JP2014516069A 2011-06-15 2012-06-15 カロリー制限およびカロリー制限模倣物の同定用マーカー Pending JP2014518071A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2016165596A JP6904676B2 (ja) 2011-06-15 2016-08-26 カロリー制限およびカロリー制限模倣物の同定用マーカー

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161497476P 2011-06-15 2011-06-15
US61/497,476 2011-06-15
PCT/US2012/042822 WO2012174484A2 (en) 2011-06-15 2012-06-15 Identifying markers of caloric restriction and caloric restriction mimetics

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016165596A Division JP6904676B2 (ja) 2011-06-15 2016-08-26 カロリー制限およびカロリー制限模倣物の同定用マーカー

Publications (2)

Publication Number Publication Date
JP2014518071A true JP2014518071A (ja) 2014-07-28
JP2014518071A5 JP2014518071A5 (https=) 2015-05-28

Family

ID=47357787

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2014516069A Pending JP2014518071A (ja) 2011-06-15 2012-06-15 カロリー制限およびカロリー制限模倣物の同定用マーカー
JP2016165596A Active JP6904676B2 (ja) 2011-06-15 2016-08-26 カロリー制限およびカロリー制限模倣物の同定用マーカー
JP2018199144A Pending JP2019037240A (ja) 2011-06-15 2018-10-23 カロリー制限およびカロリー制限模倣物の同定用マーカー
JP2021002732A Active JP7355766B2 (ja) 2011-06-15 2021-01-12 カロリー制限およびカロリー制限模倣物の同定用マーカー
JP2022096412A Pending JP2022113834A (ja) 2011-06-15 2022-06-15 カロリー制限およびカロリー制限模倣物の同定用マーカー

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2016165596A Active JP6904676B2 (ja) 2011-06-15 2016-08-26 カロリー制限およびカロリー制限模倣物の同定用マーカー
JP2018199144A Pending JP2019037240A (ja) 2011-06-15 2018-10-23 カロリー制限およびカロリー制限模倣物の同定用マーカー
JP2021002732A Active JP7355766B2 (ja) 2011-06-15 2021-01-12 カロリー制限およびカロリー制限模倣物の同定用マーカー
JP2022096412A Pending JP2022113834A (ja) 2011-06-15 2022-06-15 カロリー制限およびカロリー制限模倣物の同定用マーカー

Country Status (6)

Country Link
US (4) US20130178379A1 (https=)
EP (1) EP2721155A4 (https=)
JP (5) JP2014518071A (https=)
KR (1) KR20140041710A (https=)
CN (4) CN107217051A (https=)
WO (1) WO2012174484A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11345963B2 (en) 2018-05-07 2022-05-31 Ebay Inc. Nucleic acid taggants
CN113712121B (zh) * 2021-08-31 2023-08-15 河南牧业经济学院 尼克酰胺在改善泌乳期奶山羊乳成分中的应用
CN119700977B (zh) * 2024-12-11 2025-08-22 山东省妇幼保健院 Psmg4基因在制备心脏疾病治疗药物及相关诊断产品中的应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006521809A (ja) * 2003-03-12 2006-09-28 ザ レジェンツ オブ ザ ユニバーシティー オブ カリフォルニア カロリー制限を評価する方法およびカロリー制限模倣剤を同定する方法
JP2008524256A (ja) * 2004-12-17 2008-07-10 アラン ビー. キャッシュ 寿命を拡大させ、かつ加齢関連疾患の発症を遅らせるための方法
WO2010104573A1 (en) * 2009-03-11 2010-09-16 Nestec S.A. Tissue-specific aging biomarkers

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309853B1 (en) * 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
PL363426A1 (en) * 2001-03-09 2004-11-15 Societe Des Produits Nestle S.A. Composition improving age-related physiological deficits and increasing longevity
CA2450126A1 (en) * 2001-06-26 2003-01-09 Wisconsin Alumni Research Foundation Gene expression alterations underlying the retardation of aging by caloric restriction in mammals
CA2477911A1 (en) * 2002-03-15 2003-09-25 Max F. Rothschild Novel hmga alleles and use of the same as genetic markers for growth, fatness, meat quality and feed efficiency traits
US7737158B2 (en) * 2005-10-11 2010-06-15 Washington University Processes for regulating blood glucose in a mammal
WO2007088046A2 (en) * 2006-02-01 2007-08-09 Nestec S.A. Nutritional system and methods for increasing longevity
WO2007109102A2 (en) * 2006-03-16 2007-09-27 Biomarker Pharmaceutical Methods for interventions and testing for caloric restriction (cr) mimetics
EP1956096A1 (en) * 2007-02-12 2008-08-13 Université Catholique de Louvain Method, device and kit for determining conditions related to a dysfunction of the renal proximal tubule
DK2279263T3 (da) * 2008-04-30 2013-11-11 Integrated Dna Tech Inc Rnase-h-baserede assays med anvendelse af modificerede rna-monomerer
WO2010005533A2 (en) * 2008-06-30 2010-01-14 The Johns Hopkins University Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa
US20120094300A1 (en) * 2009-04-24 2012-04-19 Robin Shaw Bin1 as a Prognostic Marker in Cardiovascular Disease
JP2012115374A (ja) * 2010-11-30 2012-06-21 Kao Corp Acaca発現抑制方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006521809A (ja) * 2003-03-12 2006-09-28 ザ レジェンツ オブ ザ ユニバーシティー オブ カリフォルニア カロリー制限を評価する方法およびカロリー制限模倣剤を同定する方法
JP2008524256A (ja) * 2004-12-17 2008-07-10 アラン ビー. キャッシュ 寿命を拡大させ、かつ加齢関連疾患の発症を遅らせるための方法
WO2010104573A1 (en) * 2009-03-11 2010-09-16 Nestec S.A. Tissue-specific aging biomarkers

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6016006977; 'Adipose tissue energy metabolism: altered gene expression profile of mice subjected to long-term cal' he FASEB Journal , 2003 *
JPN6016006980; Aging Cell Vol.8, 2009, p.484-495 *

Also Published As

Publication number Publication date
JP6904676B2 (ja) 2021-07-21
WO2012174484A2 (en) 2012-12-20
JP2019037240A (ja) 2019-03-14
JP2021052803A (ja) 2021-04-08
EP2721155A4 (en) 2014-12-31
JP7355766B2 (ja) 2023-10-03
WO2012174484A3 (en) 2013-04-11
JP2016195613A (ja) 2016-11-24
US20160257996A1 (en) 2016-09-08
US20160186257A1 (en) 2016-06-30
JP2022113834A (ja) 2022-08-04
CN107217051A (zh) 2017-09-29
CN113801878A (zh) 2021-12-17
US20130178379A1 (en) 2013-07-11
CN103732745A (zh) 2014-04-16
EP2721155A2 (en) 2014-04-23
CN121271860A (zh) 2026-01-06
KR20140041710A (ko) 2014-04-04
US20160208330A1 (en) 2016-07-21

Similar Documents

Publication Publication Date Title
US20090191568A1 (en) Methods and compositions for predicting compliance with an antidepressant treatment regimen
US9469875B2 (en) Methods for detection of depressive disorders
JP2022113834A (ja) カロリー制限およびカロリー制限模倣物の同定用マーカー
US10544462B2 (en) Biomarkers predictive of predisposition to depression and response to treatment
Imboden et al. The common G‐allele of interleukin‐18 single‐nucleotide polymorphism is a genetic risk factor for atopic asthma. The SAPALDIA Cohort Study
WO2008144316A1 (en) Blood biomarkers for psychosis
US20150065530A1 (en) Biomarker associated with irritable bowel syndrome and crohn's disease
US20170137880A1 (en) Method for treating depression and major depressive disorder
US10233501B2 (en) Biomarkers predictive of predisposition to depression and response to treatment
WO2017161289A1 (en) Method for identifying clinical trial responders from a placebo group in major depression
US20230257814A1 (en) Methods and kits for treating or diagnosing cannabinoid hyperemesis syndrome
KR101402919B1 (ko) 중풍 분류용 뉴로펩타이드 y 유전자 다형성 마커 및 이의 용도
CN114350781A (zh) 检测coqr2基因多态性位点snp分型的引物探针组合、试剂盒及其应用
CN102888451A (zh) 一种检测黄牛ppargc1a基因单核苷酸多态性的方法
Yan et al. No association between Id2 gene methylation and tetralogy of Fallot: a case-control study in China children

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150406

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150406

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160226

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160411

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160826

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20160826

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20161228